NCT02122185 2026-03-27
Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
University of Chicago
Phase 2 Completed
Clinical Trials
21 trialsNCT04576104 2026-01-21
Megestrol Acetate Compared With Megestrol Acetate and Metformin to Prevent Endometrial Cancer
Northwestern University
Phase 2 Active not recruiting
NCT01797523 2025-11-06
A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial Carcinoma
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT02755844 2025-10-02
ENDOLA
Hospices Civils de Lyon
Phase 1/2 Completed
NCT03675893 2025-06-15
RESOLVE: Abemaciclib + Letrozole +/- Metformin, Zotatifin, or Gedatolisib in Endometrial or Low-Grade Serous Ovarian Cancer
Dana-Farber Cancer Institute
Phase 2 Recruiting
NCT04275713 2025-01-20
METOXY-LACC
Oslo University Hospital
Phase 2 Completed
NCT06353061 2025-01-14
Chemoradiotherapy With or Without Metformin in Locally Advanced Cervical Cancer
Peking Union Medical College Hospital
Phase 2 Recruiting
NCT02035787 2024-12-18
Metformin With the Levonorgestrel-Releasing Intrauterine Device for the Treatment of Complex Atypical Hyperplasia (CAH) and Endometrial Cancer (EC) in Non-surgical Patients
UNC Lineberger Comprehensive Cancer Center
Phase 2 Completed
NCT03378297 2024-10-30
IMPACT
Haukeland University Hospital
Phase EARLY_PHASE1 Completed
NCT02431676 2024-08-28
SPIRIT
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT02312661 2024-05-06
OVMET
University Medical Center Groningen
Phase 1 Completed
NCT04792749 2023-04-13
Clinical Effects of Metformin on Fertility-sparing Treatment for Early Endometrial Cancer
Samsung Medical Center
Phase 3 Unknown
NCT02394652 2021-04-21
The Potential for Metformin to Improve Tumor Oxygenation in Locally Advanced Cervix Cancer: A Phase II Randomized Trial
University Health Network, Toronto
Phase 2 Completed
NCT02050009 2019-02-20
Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Fox Chase Cancer Center
Phase 1 Withdrawn
NCT03538704 2018-05-29
ECFerSp
Peking University People's Hospital
Phase NA Unknown
NCT01579812 2018-05-25
Evaluation of Metformin, Targeting Cancer Stem Cells for Prevention of Relapse in Gynecologic Patients
University of Michigan Rogel Cancer Center
Phase 2 Completed
NCT01205672 2017-06-02
Evaluation of the Molecular Effects of Metformin on the Endometrium in Patients With Endometrial Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Completed
NCT02437812 2017-02-28
Study of Paclitaxel, Carboplatin and Oral Metformin in the Treatment of Advanced Stage Ovarian Carcinoma
Gynecologic Oncology Associates
Phase 2 Unknown
NCT02990728 2016-12-13
Mirena® ± Metformin as Fertility-preserving Treatment for Young Asian Women With Early Endometrial Cancer
Chang Gung Memorial Hospital
Phase 2 Unknown
NCT02042495 2016-08-30
Endometrial Cancer Biomarker Changes Following Exposure to Metformin
Jewish General Hospital
Phase 2 Withdrawn
NCT01911247 2013-07-30
Preoperative Window Study of Metformin for the Treatment of Endometrial Cancer
UNC Lineberger Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed